Horizon Technology Finance closed a $30 million venture loan facility for Interior Define, a direct-to-consumer furniture brand.
Horizon Technology Finance provided an additional venture loan in the principal amount of $5 million to Everstream Analytics, a provider of supply chain risk management software and an existing Horizon portfolio company.
Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, completed a $25 million long-term debt facility led by Horizon Technology Finance.
Horizon Technology Finance, a specialty finance company providing capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services and sustainability industries, closed a $30 million venture loan facility for Dropoff.
Horizon Technology Finance led a $15 million venture loan facility to Spineology. Horizon Technology Finance funded $5 million of the initial $10 million draw and a private investment vehicle managed by Horizon Technology Finance Management, Horizon Technology Finance’s advisor, funded $5 million.
Horizon Technology Finance along with lending partner Trinity Capital, provided a $40 million venture loan to Nexii Building Solutions, a green construction technology company focused on creating environmentally-friendly, durable, cost-efficient and disaster-resilient buildings.
Horizon Technology Finance led a $15 million venture loan facility to Branded Online (d.b.a. Nogin), of which Horizon funded $5 million of the initial $10 million draw, while a private investment vehicle managed by Horizon Technology Finance Management funded $5 million.
Horizon Technology Finance Management, a registered investment advisor that underwrites and manages secured loans, made several promotions and new hires, including elevating John C. Bombara, Daniel S. Devorsetz and Daniel R. Trolio to executive vice president roles.
Horizon Technology Finance appointed Daniel S. Devorsetz COO, effective immediately. In addition, Horizon Technology Finance concurrently appointed Devorsetz COO of its external investment advisor, Horizon Technology Finance Management.
Cerecor, a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan diseases, entered into a debt financing agreement for up to $35 million in term loans with Horizon Technology Finance.